Cindy Sander

10.3k total citations · 4 hit papers
84 papers, 5.2k citations indexed

About

Cindy Sander is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Cindy Sander has authored 84 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 47 papers in Immunology and 31 papers in Molecular Biology. Recurrent topics in Cindy Sander's work include Cancer Immunotherapy and Biomarkers (35 papers), Immunotherapy and Immune Responses (31 papers) and CAR-T cell therapy research (23 papers). Cindy Sander is often cited by papers focused on Cancer Immunotherapy and Biomarkers (35 papers), Immunotherapy and Immune Responses (31 papers) and CAR-T cell therapy research (23 papers). Cindy Sander collaborates with scholars based in United States, Germany and Switzerland. Cindy Sander's co-authors include John M. Kirkwood, Hassane M. Zarour, Julien Fourcade, Zhaojun Sun, Philippe Guillaume, Immanuel F. Luescher, Vijay K. Kuchroo, Ahmad A. Tarhini, Ornella Pagliano and Mourad Benallaoua and has published in prestigious journals such as Science, Cell and Journal of Clinical Investigation.

In The Last Decade

Cindy Sander

81 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients

2010 1.0k citations Julien Fourcade, Zhaojun Sun et al. The Journal of Experimental Medicine profile →
TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients

2015 608 citations Joë-Marc Chauvin, Ornella Pagliano et al. profile →
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity

2017 432 citations Cindy Sander, John M. Kirkwood et al. Cell profile →
Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity

2024 75 citations Anthony R. Cillo, Carly Cardello et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cindy Sander United States	28	3.7k	3.6k	1.2k	353	330	84	5.2k
Matthew D. Vesely United States	18	2.4k 0.6×	2.6k 0.7×	936 0.8×	429 1.2×	400 1.2×	52	4.1k
Wojciech Szeliga United States	19	3.0k 0.8×	4.0k 1.1×	1.5k 1.2×	367 1.0×	564 1.7×	26	5.7k
Andrea Schietinger United States	25	3.1k 0.8×	3.5k 1.0×	1.2k 1.0×	305 0.9×	336 1.0×	41	5.1k
Alexander C. Huang United States	19	2.6k 0.7×	2.5k 0.7×	951 0.8×	326 0.9×	271 0.8×	42	4.0k
Vaios Karanikas Switzerland	25	2.4k 0.6×	2.7k 0.8×	1.3k 1.1×	445 1.3×	341 1.0×	52	4.1k
Jianda Yuan United States	36	3.5k 0.9×	3.4k 1.0×	1.1k 0.9×	597 1.7×	243 0.7×	96	5.3k
Jeong Kim United States	13	2.2k 0.6×	3.9k 1.1×	1.0k 0.9×	272 0.8×	265 0.8×	18	5.2k
Yasutoshi Agata Japan	21	2.8k 0.8×	3.5k 1.0×	1.3k 1.1×	402 1.1×	401 1.2×	35	5.5k
Begonya Comin-Anduix United States	28	2.6k 0.7×	2.1k 0.6×	1.7k 1.5×	416 1.2×	338 1.0×	42	4.3k
Cora D. Arthur United States	13	2.7k 0.7×	3.2k 0.9×	1.2k 1.0×	268 0.8×	651 2.0×	16	4.5k

Countries citing papers authored by Cindy Sander

Since Specialization

Citations

This map shows the geographic impact of Cindy Sander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy Sander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy Sander more than expected).

Fields of papers citing papers by Cindy Sander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy Sander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy Sander. The network helps show where Cindy Sander may publish in the future.

Co-authorship network of co-authors of Cindy Sander

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy Sander. A scholar is included among the top collaborators of Cindy Sander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy Sander. Cindy Sander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adamik, Juraj, Hongzhi Wang, Mary Jo Buffo, et al.. (2025). Serum Arginase−1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness. OncoImmunology. 14(1). 2595764–2595764.

Zang, Yan, Hong Wang, Cindy Sander, et al.. (2024). A phase II trial of nivolumab plus axitinib in patients with anti-PD1 refractory advanced melanoma.. Journal of Clinical Oncology. 42(16_suppl). TPS9600–TPS9600. 1 indexed citations

Dong, Bowen, Nataša Obermajer, Takemasa Tsuji, et al.. (2024). NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs. Cancer Immunology Research. 12(10). 1421–1437. 3 indexed citations

Cillo, Anthony R., Carly Cardello, Feng Shan, et al.. (2024). Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity. Cell. 187(16). 4373–4388.e15. 75 indexed citations breakdown →

Karapetyan, Lilit, Andrew Knight, Hong Wang, et al.. (2024). Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas. Journal for ImmunoTherapy of Cancer. 12(11). e009231–e009231. 5 indexed citations

Augustin, Ryan C., Sarah Newman, Marion Joy, et al.. (2023). Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma. Journal for ImmunoTherapy of Cancer. 11(10). e007567–e007567. 8 indexed citations

Maguire, William F., Cindy Sander, Laura K. Ferris, et al.. (2023). Development and Narrow Validation of Computer Vision Approach to Facilitate Assessment of Change in Pigmented Cutaneous Lesions. SHILAP Revista de lepidopterología. 3(2). 100181–100181. 2 indexed citations

Augustin, Ryan C., Marion Joy, Peter C. Lucas, et al.. (2023). 888 Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma. SHILAP Revista de lepidopterología. A989–A989. 1 indexed citations

Mangler, Mandy, et al.. (2022). Pregnancy associated atypical hemolytic uremic syndrome presenting with preeclampsia with HELLP syndrome and following treatment with Eculizumab. Case Reports in Perinatal Medicine. 12(1). 20220016–20220016. 1 indexed citations

10.

Beale, Holly C., Cindy Sander, Carla J. Connelly, et al.. (2022). TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma. Science. 378(6620). 664–668. 24 indexed citations

11.

Chauvin, Joë-Marc, Mignane Ka, Ornella Pagliano, et al.. (2020). IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma. Clinical Cancer Research. 26(20). 5520–5533. 114 indexed citations

12.

Karapetyan, Lilit, Xi Yang, Hong Wang, et al.. (2020). Indoor tanning exposure in association with multiple primary melanoma. Cancer. 127(4). 560–568. 7 indexed citations

13.

Tarhini, Ahmad A., Haris Zahoor, Jennifer H. Yearley, et al.. (2015). Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma. Journal of Translational Medicine. 13(1). 319–319. 27 indexed citations

14.

Sun, Zhaojun, Julien Fourcade, Ornella Pagliano, et al.. (2015). IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells. Cancer Research. 75(8). 1635–1644. 141 indexed citations

15.

Tarhini, Ahmad A., Haris Zahoor, Yan Lin, et al.. (2015). Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma. Journal for ImmunoTherapy of Cancer. 3(1). 39–39. 306 indexed citations

16.

Fourcade, Julien, Zhaojun Sun, Ornella Pagliano, et al.. (2013). PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen–Specific CD8+ T Cells Induced by Melanoma Vaccines. Cancer Research. 74(4). 1045–1055. 175 indexed citations

17.

Fourcade, Julien, Zhaojun Sun, Ornella Pagliano, et al.. (2011). CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1. Cancer Research. 72(4). 887–896. 291 indexed citations

18.

Fourcade, Julien, Zhaojun Sun, Mourad Benallaoua, et al.. (2010). Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients. The Journal of Experimental Medicine. 207(10). 2175–2186. 1032 indexed citations breakdown →

19.

Fourcade, Julien, Pavol Kudela, Zhaojun Sun, et al.. (2009). PD-1 Is a Regulator of NY-ESO-1-Specific CD8+ T Cell Expansion in Melanoma Patients. The Journal of Immunology. 182(9). 5240–5249. 131 indexed citations

20.

Kokkinakis, Demetrius M., Anthony G. Brickner, John M. Kirkwood, et al.. (2006). Mitotic Arrest, Apoptosis, and Sensitization to Chemotherapy of Melanomas by Methionine Deprivation Stress. Molecular Cancer Research. 4(8). 575–589. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact